Cyanotech Co. (OTCMKTS:CYAN) Short Interest Update

Cyanotech Co. (OTCMKTS:CYAN) saw a significant growth in short interest in July. As of July 15th, there was short interest totaling 2,938 shares, a growth of 2,477.2% from the June 30th total of 114 shares. Approximately 0.1% of the shares of the stock are short sold. Based on an average daily volume of 3,344 shares, the days-to-cover ratio is currently 0.9 days.

Cyanotech Price Performance

CYAN remained flat at $0.53 during trading on Friday. The company has a market cap of $3.91 million, a PE ratio of -2.12 and a beta of 0.12. Cyanotech has a 12 month low of $0.21 and a 12 month high of $0.57. The business has a fifty day simple moving average of $0.48 and a two-hundred day simple moving average of $0.42. The company has a quick ratio of 0.42, a current ratio of 1.02 and a debt-to-equity ratio of 0.13.

Cyanotech (OTCMKTS:CYAN) last announced its earnings results on Monday, June 29th. The biotechnology company reported $0.00 earnings per share for the quarter. Cyanotech had a negative return on equity of 16.24% and a negative net margin of 4.82%.

About Cyanotech

Cyanotech Corp. engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. Its products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant, which is used as a human dietary supplement and dietary ingredient to support and maintain the body’s natural inflammatory response, enhance skin, and support eye, joint, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids.